ESC Premium Access

When should I use reversal agents for NOACs?

Congress Session

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
3 followers

3 more presentations in this session

Reversal of the thrombin inhibitor dabigatran.

Speaker: Associate Professor A. Niessner (Vienna, AT)

Thumbnail

Reversal of FXa inhibitors.

Speaker: Associate Professor S. Wassmann (Munich, DE)

Thumbnail

Will the availability of specific reversal agents change the use of NOACs?

Speaker: Professor F. Verheugt (Amsterdam, NL)

Thumbnail

Access the full session

Reversal of NOACs' effect: when and how?

Speakers: Professor G. Lip, Associate Professor A. Niessner, Associate Professor S. Wassmann, Professor F. Verheugt
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk